How have CPIX shares performed in 2024?

Cumberland Pharmaceuticals' stock was trading at $1.7917 on January 1st, 2024. Since then, CPIX stock has decreased by 10.7% and is now trading at $1.60. View the best growth stocks for 2024 here .

Are investors shorting Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 17,000 shares, a drop of 16.7% from the March 15th total of 20,400 shares. Based on an average daily trading volume, of 11,800 shares, the short-interest ratio is presently 1.4 days. Currently, 0.2% of the shares of the company are short sold. View Cumberland Pharmaceuticals' Short Interest .

When is Cumberland Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our CPIX earnings forecast .

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) posted its earnings results on Tuesday, March, 5th. The specialty pharmaceutical company reported ($0.12) earnings per share for the quarter. The specialty pharmaceutical company had revenue of $9.35 million for the quarter. Cumberland Pharmaceuticals had a negative net margin of 15.87% and a positive trailing twelve-month return on equity of 6.84%.

What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO?

9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com . A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cumberland Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC) , VIVUS (VVUS) , CymaBay Therapeutics (CBAY) , Sorrento Therapeutics (SRNE) , SCYNEXIS (SCYX) , VBI Vaccines (VBIV) , Akero Therapeutics (AKRO) , Cerecor (CERC) , Xeris Biopharma (XERS) .

How do I buy shares of Cumberland Pharmaceuticals?

Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CPIX

Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free CPIX Stock Alerts

$1.60

-0.05 (-3.03%)

(As of 04/19/2024 ET)

Compare

Today's Range: $1.59
▼
$1.61
50-Day Range: $1.55
▼
$2.21
52-Week Range: $1.43
▼
$2.36

Volume: 786 shs
Average Volume: 11,448 shs
Market Capitalization: $22.68 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Cumberland Pharmaceuticals alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

CPIX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CPIX Stock News Headlines

April 19, 2024 | msn.com

Parents alerted to fuel spill at Cumberland Valley school

April 19, 2024 | msn.com

Traffic backed up following crash on I-81 in Cumberland County

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

April 19, 2024 | msn.com

'Total loss': Cumberland County home destroyed in fire

April 19, 2024 | msn.com

Cumberland County Board of Elections announces polling place changes for Tuesday's primary

April 19, 2024 | msn.com

Cumberland Heights breaks ground on new facility

April 19, 2024 | msn.com

Cumberland Valley leaders contradict school board bosses: Pancholy’s ‘assembly should have been allowed’

April 19, 2024 | msn.com

Troopers looking for suspect in attempted child luring incident in Cumberland County

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

April 19, 2024 | nj.com

Robeson sparks Highland to walk-off win over Cumberland - Baseball recap

April 19, 2024 | msn.com

State police investigate attempted child luring in Cumberland County

April 19, 2024 | msn.com

Cumberland police searching for missing 91-year-old man

April 19, 2024 | msn.com

Cumberland Police seek help from public in search for missing man

April 18, 2024 | msn.com

Cumberland County school board facing backlash after canceling anti-bully assembly featuring Maulik Pancholy

April 18, 2024 | msn.com

Cumberland Gap Volunteer Fire Department raising funds for fire truck

April 18, 2024 | nj.com

Levick helps Cumberland defeat Glassboro - Baseball recap

April 17, 2024 | msn.com

Big yard sale in Cumberland County to raise money for local school district

April 17, 2024 | news.yahoo.com

Cumberland man arrested on drug charge

April 17, 2024 | msn.com

Cumberland takes advantage of Cranston West's misplays and stays undefeated; what happened

April 16, 2024 | msn.com

Cumberland Trail hike is Saturday

April 16, 2024 | news.yahoo.com

Cumberland man arrested in West Side knife incident

April 16, 2024 | msn.com

Cumberland County Prison cleared after bomb threat, police report

April 16, 2024 | news.yahoo.com

Seedtime on the Cumberland June 1 in Whitesburg

April 16, 2024 | msn.com

Prescribed burn will close campground on Cumberland Island

April 16, 2024 | msn.com

2 Hospitalized After Cumberland County Sheriff's Vehicle Struck Head-On, State Police Say

April 16, 2024 | msn.com

Cumberland County DA reveals findings of investigation into former Newville Borough manager's handling of finances

April 16, 2024 | americanbankingnews.com

Cumberland Pharmaceuticals (NASDAQ:CPIX) Research Coverage Started at StockNews.com

See More Headlines

Receive CPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/05/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/14/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: Pharmaceuticals
Current Symbol: NASDAQ:CPIX
CUSIP: 23077010
CIK: 1087294
Web: www.cumberlandpharma.com
Phone: (615) 255-0068
Fax: 615-255-0094
Employees: 91
Year Founded: 1999

Profitability

EPS (Most Recent Fiscal Year): ($0.44)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-6,280,000.00
Net Margins: -15.87%
Pretax Margin: -15.89%
Return on Equity: 6.84%
Return on Assets: 2.70%

Debt

Debt-to-Equity Ratio: 0.44
Current Ratio: 1.28
Quick Ratio: 1.11

Sales & Book Value

Annual Sales: $39.55 million
Price / Sales: 0.57
Cash Flow: $0.70 per share
Price / Cash Flow: 2.27
Book Value: $1.96 per share
Price / Book: 0.82

Miscellaneous

Outstanding Shares: 14,177,000
Free Float: 8,038,000
Market Cap: $22.68 million
Optionable: Optionable
Beta: 0.16

Social Links

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Mr. A. J. Kazimi MBA (Age 66)
Founder, Chairman, President & CEO
Comp: $952.53k
Mr. John Michael Hamm (Age 68)
VP & CFO
Comp: $258.38k
Mr. James Lowrance Herman (Age 69)
Executive VP of National Accounts & Chief Compliance Officer
Comp: $372.27k
Mr. Chris T. Bitterman (Age 59)
Vice President of Sales & Marketing
Comp: $290.87k
Mr. Todd M. Anthony (Age 63)
Vice President of Organizational Development
Comp: $304.94k
Ms. Jean W. Marstiller (Age 74)
Senior VP of Administrative Services & Corporate Secretary
Comp: $282.17k
Mr. Adam S. Mostafa (Age 43)
Managing Director
Ms. Erin Smith Gull
Senior Corporate Relations Associate

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

CPIX Stock Analysis - Frequently Asked Questions

How have CPIX shares performed in 2024?: Cumberland Pharmaceuticals' stock was trading at $1.7917 on January 1st, 2024. Since then, CPIX stock has decreased by 10.7% and is now trading at $1.60.
View the best growth stocks for 2024 here.
Are investors shorting Cumberland Pharmaceuticals?: Cumberland Pharmaceuticals saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 17,000 shares, a drop of 16.7% from the March 15th total of 20,400 shares. Based on an average daily trading volume, of 11,800 shares, the short-interest ratio is presently 1.4 days. Currently, 0.2% of the shares of the company are short sold.
View Cumberland Pharmaceuticals' Short Interest.
When is Cumberland Pharmaceuticals' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our CPIX earnings forecast.
How were Cumberland Pharmaceuticals' earnings last quarter?: Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) posted its earnings results on Tuesday, March, 5th. The specialty pharmaceutical company reported ($0.12) earnings per share for the quarter. The specialty pharmaceutical company had revenue of $9.35 million for the quarter. Cumberland Pharmaceuticals had a negative net margin of 15.87% and a positive trailing twelve-month return on equity of 6.84%.

What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO?: 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Cumberland Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS).
How do I buy shares of Cumberland Pharmaceuticals?: Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CPIX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis

About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)

CPIX Stock Price History

CPIX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Institutional Ownership

CPIX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info